Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Gastric Cancer

  Free Subscription


Articles published in J Pathol

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    November 2025
  1. SUN M, Gu Y, Wang J, Zhang Z, et al
    Clinical outcomes and immune contexture in SMARCA4-deficient gastric cancer patients.
    J Pathol. 2025 Nov 11. doi: 10.1002/path.6495.
    PubMed     Abstract available


    October 2025
  2. MANO Y, Matsusaka K, Seki M, Kita K, et al
    DNA-hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation.
    J Pathol. 2025 Oct 9. doi: 10.1002/path.6480.
    PubMed     Abstract available


    February 2025
  3. HARADA K, Sakamoto N, Kitaoka T, Nakamura Y, et al
    PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer.
    J Pathol. 2025 Feb 20. doi: 10.1002/path.6400.
    PubMed     Abstract available


    June 2024
  4. ZHOU Y, Li S, Hu Y, Xu X, et al
    Multi-regional sequencing reveals the genetic and immune heterogeneity of non-cancerous tissues in gastric cancer.
    J Pathol. 2024 Jun 6. doi: 10.1002/path.6297.
    PubMed     Abstract available


    April 2024
  5. MONSTER JL, Kemp LJ, Busslinger GA, Vliem MJ, et al
    Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer.
    J Pathol. 2024 Apr 4. doi: 10.1002/path.6277.
    PubMed     Abstract available


    March 2024
  6. DUAN S, Sawyer TW, Witten BL, Song H, et al
    Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
    J Pathol. 2024;262:362-376.
    PubMed     Abstract available


    June 2023
  7. CHOI S, Kim H, Heo YJ, Kang SY, et al
    PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
    J Pathol. 2023 Jun 21. doi: 10.1002/path.6134.
    PubMed     Abstract available


  8. ZHANG J, Chen B, Wang Y, Liu X, et al
    The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer.
    J Pathol. 2023 Jun 5. doi: 10.1002/path.6091.
    PubMed     Abstract available


    May 2023
  9. GOLDENRING JR
    Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
    J Pathol. 2023 May 5. doi: 10.1002/path.6089.
    PubMed     Abstract available


    April 2023
  10. YING L, Liu P, Ding Z, Wray-McCann G, et al
    Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell MALT lymphoma in a mouse model.
    J Pathol. 2023;259:402-414.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.